Topics

Avacta Group - Affimer drug conjugates attracting interest

11:59 EDT 11 Oct 2019 | FinanzNachrichten

Avacta has announced a collaboration and licensing agreement with ADC Therapeutics to develop multiple Affimer drug conjugates. The conjugates will combine Avacta's Affimers with ADC's warhead and ...

Original Article: Avacta Group - Affimer drug conjugates attracting interest

NEXT ARTICLE

More From BioPortfolio on "Avacta Group - Affimer drug conjugates attracting interest"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...